Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Sales | 2,032,379 | 1,801,389 | 1,647,155 | 1,530,460 | 1,428,205 |
| Cost of Goods | 473,399 | 409,700 | 383,045 | 329,414 | 321,531 |
| Gross Profit | 1,558,980 | 1,391,689 | 1,264,110 | 1,201,046 | 1,106,674 |
| Operating Expenses | 493,941 | 497,983 | 503,094 | 393,144 | 396,059 |
| Operating Income | 1,065,438 | 894,406 | 761,061 | 808,316 | 711,146 |
| Interest Expense | 17,290 | 17,217 | 18,484 | 16,671 | 16,433 |
| Other Income | 11,299 | 14,017 | 12,923 | 4,158 | 19,038 |
| Pre-tax Income | 1,059,447 | 891,206 | 755,500 | 795,803 | 713,751 |
| Income Tax | 260,054 | 220,728 | 186,355 | 209,227 | 156,157 |
| Net Income Continuous | 799,393 | 670,478 | 569,145 | 586,576 | 557,594 |
| Minority Interests | -2,819 | -2,555 | -2,253 | -2,536 | -2,369 |
| Net Income | $802,212 | $673,033 | $571,398 | $589,112 | $559,963 |
| EPS Basic Total Ops | 0.44 | 0.38 | 0.32 | 0.33 | 0.31 |
| EPS Basic Continuous Ops | 0.44 | 0.37 | 0.31 | 0.32 | 0.31 |
| EPS Diluted Total Ops | 0.43 | 0.36 | 0.31 | 0.32 | 0.29 |
| EPS Diluted Continuous Ops | 0.43 | 0.36 | 0.30 | 0.31 | 0.29 |
| EBITDA(a) | $1,129,547 | $951,457 | $813,696 | $847,464 | $751,539 |